LiDCO Group Plc Stock price

Equities

LID

GB0030546849

Advanced Medical Equipment & Technology

Delayed London S.E. 11:35:19 2021-01-08 am EST 5-day change 1st Jan Change
11.75 GBX -.--% Intraday chart for LiDCO Group Plc -.--% -.--%
Sales 2019 7.32M 9.24M Sales 2020 7.55M 9.52M Capitalization 11.35M 14.32M
Net income 2019 -1M -1.26M Net income 2020 -1M -1.26M EV / Sales 2019 1.22 x
Net cash position 2019 1.72M 2.17M Net cash position 2020 1.12M 1.42M EV / Sales 2020 1.36 x
P/E ratio 2019
-5.47 x
P/E ratio 2020
-11 x
Employees -
Yield 2019 *
-
Yield 2020
-
Free-Float 41.69%
More Fundamentals * Assessed data
Dynamic Chart
Masimo Corporation completed the acquisition of LiDCO Group Plc from Herald Investment Management Limited, Eiffel Investment Group S.A.S., Vermeer Partners, P Brewer and others. CI
LiDCO : Takeover Offer by Masimo Declared Unconditional, Acceptances Exceed 90% MT
LiDCO : Masimo's Takeover Offer for LiDCO Extended for Two Weeks as Acceptances Reach 75% MT
LiDCO : Surges 68% on Acquisition by Masimo in $40 Million Deal MT
Masimo Corporation reached agreement on the terms of a recommended cash offer to acquire LiDCO Group Plc from Herald Investment Management Limited, Eiffel Investment Group S.A.S., Vermeer Partners, P Brewer and others for £30.4 million. CI
LiDCO Group Plc Provides Sales Guidance for the Second Half of Financial Year Ending January 31, 2021 CI
Lidco Group plc Reports Earnings Results for the Half Year Ended July 31, 2020 CI
LiDCO Group Plc Provides Sales Guidance for the Three Months Ending 30 April 2020 CI
Lidco Group plc Reports Earnings Results for the Full Year Ended January 31, 2020 CI
LiDCO Group plc Reports Revenues Results for the Full Year Ended 31 January 2020 CI
LiDCO Group Plc Announces LiDCOrapidv3 Launched in China CI
Lidco Group plc Reports Earnings Results for the Half Year Ended July 31, 2019 CI
LiDCO Signs Variation Agreement to Existing Commercial Collaboration with Cnsystems Medizintechnik AG CI
LiDCO Group plc Appoints James G. Wetrich to the Board, as A Non-Executive Director CI
LiDCO Announces Latest Cardiac Output Monitor with Non-Invasive Technology Has Received Regulatory Approval for Commercial Sale in China CI
More news
Managers TitleAgeSince
Director of Finance/CFO 45 21-01-11
Chief Operating Officer - -
Chief Operating Officer 43 21-01-11
Members of the board TitleAgeSince
Director/Board Member 49 15-06-14
Director of Finance/CFO 45 21-01-11
Chief Operating Officer 43 21-01-11
More insiders
Lidco Group Ltd, formerly LiDCO Group Plc, is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment. The Company's products include LiDCOplus, a computer-based platform monitor; LiDCOrapid, a cardiac output monitor; LiDCOview, a graphical display, and LiDCOunity, which is its hemodynamic monitor. Its LiDCOrapid is designed for multi-parameter monitoring of both depth of anesthesia and fluids. Its products are used in the treatment of high-risk patients in both critical care units and in the operating theatre. They monitor the amount of blood flowing around the body helping clinicians and nurses to ensure that organs are kept perfused with oxygenated blood.
More about the company
  1. Stock
  2. Equities
  3. Stock LiDCO Group Plc - London S.E.